Robert Paul Discordia, Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 15,000 shares at $5.86 ($88K) on 2019-08-12, disclosed to the SEC on 2019-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |